Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0856 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.4797 | 0.5896 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0024 | 0.1652 | 0.2184 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0018 | 0.0778 | 0.0957 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0018 | 0.0778 | 0.0957 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.0856 | 0.5 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0018 | 0.0778 | 0.1029 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0038 | 0.3783 | 0.5 |
Schistosoma mansoni | zinc finger protein | 0.0016 | 0.0499 | 0.0613 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0.0856 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.4797 | 0.5896 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0856 | 0.1052 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0064 | 0.7565 | 1 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0022 | 0.1348 | 0.1446 |
Echinococcus multilocularis | zinc finger protein | 0.0021 | 0.118 | 0.1559 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.0856 | 0.5 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0019 | 0.0876 | 0.094 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0019 | 0.0856 | 1 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0045 | 0.4746 | 0.6273 |
Schistosoma mansoni | zinc finger protein | 0.0021 | 0.118 | 0.145 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0856 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.9319 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.4797 | 0.634 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0024 | 0.1652 | 0.2031 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0856 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0018 | 0.0778 | 0.0957 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.4797 | 0.634 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0856 | 0.0856 |
Echinococcus granulosus | methyl CpG binding domain protein 2 | 0.0018 | 0.0778 | 0.1029 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0024 | 0.1652 | 0.2184 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0045 | 0.4746 | 0.4746 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.4547 | 0.488 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.4797 | 0.5896 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0038 | 0.3783 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0045 | 0.4797 | 0.5147 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0042 | 0.4306 | 1 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0856 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0041 | 0.4159 | 0.4159 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0.0856 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0049 | 0.536 | 0.6588 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0856 | 0.1052 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0019 | 0.0856 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0045 | 0.4797 | 0.4797 |
Schistosoma mansoni | bromodomain containing protein | 0.0067 | 0.8135 | 1 |
Echinococcus multilocularis | methyl CpG binding domain protein 2 | 0.0018 | 0.0778 | 0.1029 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.4797 | 0.634 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.4797 | 0.634 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0042 | 0.4306 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0856 | 0.1132 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0499 | 0.0613 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0045 | 0.4746 | 0.5092 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0064 | 0.7565 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0019 | 0.0856 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0018 | 0.0778 | 0.0957 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0.0856 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.3863 | 0.4146 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.4171 | 0.4475 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0049 | 0.536 | 0.6588 |
Echinococcus granulosus | zinc finger protein | 0.0021 | 0.118 | 0.1559 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0045 | 0.4746 | 0.6273 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0856 | 0.0919 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.1348 | 0.1657 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.4851 | 0.5206 |
Brugia malayi | PHD-finger family protein | 0.0027 | 0.2029 | 0.2029 |
Toxoplasma gondii | exonuclease III APE | 0.0019 | 0.0856 | 0.5 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0856 | 0.1132 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0018 | 0.0778 | 0.1029 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0778 | 0.0835 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | = 100 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.